DexCom
DXCM
DXCM
900 hedge funds and large institutions have $42.9B invested in DexCom in 2023 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 339 increasing their positions, 344 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
900
Holders Change
-16
Holders Change %
-1.75%
% of All Funds
14.4%
Holding in Top 10
18
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-30.77%
% of All Funds
0.29%
New
91
Increased
339
Reduced
344
Closed
92
Calls
$465M
Puts
$478M
Net Calls
-$13.1M
Net Calls Change
-$8.51M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$230M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$210M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$158M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$98.1M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$94.6M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$223M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$220M |
| 3 |
Sands Capital Management
Arlington,
Virginia
|
-$206M |
| 4 |
Millennium Management
New York
|
-$141M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$97.1M |
